{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:25:06Z","timestamp":1760297106097},"reference-count":40,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1080\/1042819032000159825","type":"journal-article","created":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T16:40:39Z","timestamp":1078850439000},"page":"937-944","source":"Crossref","is-referenced-by-count":22,"title":["Rituximab Followed by Cladribine in the Treatment of Heavily Pretreated Patients with Indolent Lymphoid Malignancies"],"prefix":"10.1080","volume":"45","author":[{"given":"Tadeusz","family":"Robak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Smolewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Urbanska-Rys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Gora-Tybor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy Z","family":"Blonski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kasznicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402639"},{"key":"CIT0002","first-page":"205","volume":"45","author":"Robak T","year":"2003","journal-title":"\"Monoclonal antibodies in the treatment of chronic lymphoid leukemias\", Leukemia and Lymphoma"},{"key":"CIT0003","first-page":"1326","volume":"98","author":"Huhn D.","year":"2001","journal-title":"\u201eRituximab therapy of patients with B-cell chronic lymphocytic leukemia\", Blood"},{"key":"CIT0004","author":"Davis TA.","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0005","first-page":"1927","volume":"92","author":"Coiffier B.","year":"1998","journal-title":"a multicenter phase II study\", Blood"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","author":"McLaughlin P","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0007","first-page":"12, 177 \u2014 186","author":"Demidem A.","year":"1997","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"CIT0008","first-page":"33","volume":"87","author":"Chow KU.","year":"2002","journal-title":"role of cytokines, complement, and caspases\", Haematologica"},{"key":"CIT0009","first-page":"2961","volume":"20","author":"Alas S.","year":"2000","journal-title":"\"Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab\", Anticancer Research"},{"key":"CIT0010","first-page":"800","volume":"114","author":"Di Gaetano N.","year":"2001","journal-title":"\"Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone\", British Journal of Haematology"},{"issue":"13","key":"CIT0011","first-page":"12 \u2014 14","volume":"29","author":"Rummel, Mi., Chow, KU., Hoelzer, D., Mitrou, P.S. and Weidmann, F.","year":"2002","journal-title":"Seminars in Oncology"},{"key":"CIT0012","first-page":"1765","volume":"100","author":"Rose A.L.","year":"2002","journal-title":"synergistic direct antiproliferative and apoptotic effects\", Blood"},{"key":"CIT0013","first-page":"2490","volume":"7","author":"Shan D.","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"CIT0014","first-page":"1015","volume":"16","author":"Robak T.","year":"2002","journal-title":"\"Alkylating agents and nucleoside analogues in the treatment of B-cell chronic lymphocytic leukemia\", Leukemia"},{"issue":"1","key":"CIT0015","first-page":"1503","volume":"100","author":"Smolewski P.","year":"2002","journal-title":"Blood"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0972"},{"key":"CIT0017","first-page":"477 \u2014481","volume":"44","author":"Savage D.G.","year":"2003","journal-title":"\"Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia\", Leukemia and Lymphoma"},{"key":"CIT0018","first-page":"6","volume":"101","author":"Byrd J.C.","year":"2003","journal-title":"results from Cancer and Leukemia Group B 9712 (CALG B9712)\", Blood"},{"key":"CIT0020","first-page":"87, 4990 \u2014 4997","author":"Cheson B.D.","year":"1996","journal-title":"Blood"},{"key":"CIT0021","first-page":"8835","author":"Harris N.H.","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0022","first-page":"219","volume":"46","author":"Rai KR.","year":"1975","journal-title":"\"Clinical staging of chronic lympho-cytic leukemia\", Blood"},{"key":"CIT0023","first-page":"Pp. 253","volume":"253","author":"Rai K.R","year":"1987","journal-title":"Liss"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1021\/ja00333a046"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"Cheson B.D.","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"CIT0026","first-page":"207","volume":"47","author":"Miller A.B.","year":"1981","journal-title":"\"Reporting results of cancer treatment\", Cancer"},{"key":"CIT0027","first-page":"207","volume":"47","author":"Duffy D.R.","year":"1987","journal-title":"\"Confidence intervals binomial parameter based on multistage tests\", Biometrics"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2002.0222"},{"key":"CIT0030","author":"Maloney D.G","year":"1997","journal-title":"Blood"},{"key":"CIT0031","first-page":"451 \u2014455","volume":"41","author":"Buckstein R.J.","year":"2001","journal-title":"\"Prolonge molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab\", Leukemia and Lymphoma"},{"key":"CIT0032","first-page":"36 \u2014 40","volume":"29","author":"Czuczman M.S.","year":"2002","journal-title":"\"Rituximab in combination with CHOP or fludarabine in low-grade lymphoma\", Seminars in Oncology"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50024"},{"key":"CIT0034","first-page":"1288","volume":"20","author":"Howard O.M.","year":"2002","journal-title":"molecular complete responses are not predictive of progression-free survival\", Journal of Clinical Oncology"},{"issue":"12","key":"CIT0035","first-page":"30","volume":"27","author":"Wilson W.H","year":"2000","journal-title":"Seminars in Oncology"},{"key":"CIT0036","first-page":"26, 99 \u2014 105","author":"Robak T","year":"1997","journal-title":"Leukemia and Lymphoma"},{"key":"CIT0037","first-page":"108, 357 \u2014 368","author":"Robak T.","year":"2000","journal-title":"British Journal of Haematology"},{"key":"CIT0038","first-page":"188","volume":"66","author":"Robak T.","year":"2001","journal-title":"\"Cladribine in combination with mitoxan-trone and cyclophosphamide (CMC) in the treatment of heavily pretreated patients with advanced indolent lymphoid malignancies\", European Journal of Haematology"},{"key":"CIT0039","first-page":"803","volume":"63","author":"Plosker G.L.","year":"2003","journal-title":"a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leuke-mia\", Drugs"},{"issue":"1","key":"CIT0042","first-page":"1532","volume":"98","author":"Polliack A.","year":"2001","journal-title":"Blood"},{"issue":"1","key":"CIT0043","first-page":"1393","volume":"100","author":"Cohen A.","year":"2002","journal-title":"Blood"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1042819032000159825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T22:59:29Z","timestamp":1524437969000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1042819032000159825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1080\/1042819032000159825"],"URL":"https:\/\/doi.org\/10.1080\/1042819032000159825","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}